Tevogen Bio Holdings(TVGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TVGN Tevogen Bio Holdings

Market Closed 02-14 16:00:00 EST

1.58

+0.02

+1.28%

盘后1.54

-0.04-2.53%

19:58 EST

High1.58	Low1.48	Vol1.18M
Open1.55	D1 Closing1.56	Amplitude6.41%
Mkt Cap276.58M	Tradable Cap20.95M	Total Shares175.05M
T/O1.82M	T/O Rate8.91%	Tradable Shares13.26M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"TVGN","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings","latestPrice":1.58,"timestamp":1739566800000,"preClose":1.56,"halted":0,"volume":1181705,"hourTrading":{"tag":"盘后","latestPrice":1.54,"preClose":1.58,"latestTime":"19:58 EST","volume":41050,"amount":63922.5986,"timestamp":1739581139174},"delay":0,"floatShares":13256543,"shares":175051247,"eps":-0.040796,"marketStatus":"Market Closed","change":0.02,"latestTime":"02-14 16:00:00 EST","open":1.55,"high":1.58,"low":1.48,"amount":1816635.2146705,"amplitude":0.064103,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.040796,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1739869200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.56,"preHourTrading":{"tag":"盘前","latestPrice":1.555,"preClose":1.56,"latestTime":"09:25 EST","volume":17660,"amount":27228.442304,"timestamp":1739543118855},"postHourTrading":{"tag":"盘后","latestPrice":1.54,"preClose":1.58,"latestTime":"19:58 EST","volume":41050,"amount":63922.5986,"timestamp":1739581139174},"volumeRatio":1.1421516047948912},"requestUrl":"/m/hq/s/TVGN/wiki","defaultTab":"wiki","newsList":[{"id":"2511616394","title":"Press Release: Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2511616394","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511616394?lang=en_us&edition=fundamental","pubTime":"2025-02-15 02:16","pubTimestamp":1739556960,"startTime":"0","endTime":"0","summary":"Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency. WARREN, N.J., Feb. 14, 2025  -- Tevogen Bio  , a clinical-stage specialty immunotherapy biotech company, shares a summary of the Company's 2024 financing activity at the one year anniversary of being listed on the Nasdaq exchange.-- On October 29, Tevogen Bio signed a letter of intent with CD8 Technology. Services to build an up to $50 million turn-key research and development. facility for Tevogen Bio's use. This arrangement, when finalized, will. -- On August 15, Tevogen Bio entered into a definitive agreement for a $6. million Series C Preferred Stock investment . The shares of. the Series C have a 7.5% annual dividend and are convertible into shares. of common stock after 6 months, at the election of the holder. The Series. -- On June 11, Tevogen Bio entered into a definitive agreement for up to $50. million in financing, consisting of a $36 m","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"2511069028","title":"Tevogen CEO addresses broader implications of short-selling","url":"https://stock-news.laohu8.com/highlight/detail?id=2511069028","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511069028?lang=en_us&edition=fundamental","pubTime":"2025-02-15 01:01","pubTimestamp":1739552466,"startTime":"0","endTime":"0","summary":"Tevogen Bio (TVGN) issued a statement from its Founder and CEO Ryan Saadi regarding broader implications of short-selling. “Tevogen Bio is committe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-ceo-addresses-broader-implications-of-short-selling?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-ceo-addresses-broader-implications-of-short-selling?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2510581991","title":"Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2510581991","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510581991?lang=en_us&edition=fundamental","pubTime":"2025-02-11 06:30","pubTimestamp":1739226600,"startTime":"0","endTime":"0","summary":"WARREN, N.J., Feb. 10, 2025  -- Tevogen Bio  , is a clinical-stage specialty immunotherapy biotech company. As the biopharma industry faces increasing competition from international markets and an evolving regulatory landscape, Tevogen Bio’s innovative business model positions it as a potential leader in the shift towards cost-efficient, value-driven healthcare.With the concern of Chinese pharmaceutical companies developing drugs at a faster pace and lower cost, the U.S. biotech sector faces pressure to adapt. At the same time, Robert F. Kennedy Jr., who is soon to helm the Department of Health and Human Services, has prioritized affordable healthcare, prompting industry-wide discussions on sustainability and access. Built with these industry themes in mind, Tevogen Bio exemplifies how American biotech can remain competitive and thrive amid growing concerns surrounding affordability, efficiency, and global competition.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tevogen-bios-business-model-addresses-223000195.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2509423773","title":"Tevogen Bio Meets Barda Techwatch Team, Highlighting Exactcell™ Technology’s Potential as a Scalable Medical Countermeasure","url":"https://stock-news.laohu8.com/highlight/detail?id=2509423773","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509423773?lang=en_us&edition=fundamental","pubTime":"2025-02-08 03:56","pubTimestamp":1738958217,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nFWN3OY1AI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2507520657","title":"Tevogen Bio Holdings Inc. (TVGN): Accelerating Precision Medicine with Microsoft AI Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2507520657","media":"Insider Monkey","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507520657?lang=en_us&edition=fundamental","pubTime":"2025-01-30 03:33","pubTimestamp":1738179198,"startTime":"0","endTime":"0","summary":"We recently published a list of Top 10 Trending AI Stocks on Latest News. In this article, we are going to take a look at where Tevogen Bio Holdings Inc.  stands against other top trending AI stocks on latest news.The bloodbath that triggered one of the biggest routs in US stock markets appears to be under control. Even as people across China hail the success of their homegrown tech startup DeepSeek, it’s becoming increasingly clear there is room for everyone in the artificial intelligence race. That’s the sentiment echoed across the board as it becomes clear markets might have overreacted on reports China is at the forefront of developing AI models at the lowest costs possible.The reason is simple: our research has shown that we can outperform the market by imitating the top st","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tevogen-bio-holdings-inc-tvgn-193318272.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TVGN","TVGNW","MSFT"],"gpt_icon":1},{"id":"2507524408","title":"Tevogen Bio Holdings Secures Funding for Therapeutics and AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2507524408","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507524408?lang=en_us&edition=fundamental","pubTime":"2025-01-29 06:18","pubTimestamp":1738102697,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings ( ($TVGN) ) just unveiled an announcement. On January 28, 2025, Tevogen Bio Holdings Inc. announced it received an initial $2 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tevogen-bio-holdings-secures-funding-for-therapeutics-and-ai?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tevogen-bio-holdings-secures-funding-for-therapeutics-and-ai?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TVGN","LENZ"],"gpt_icon":0},{"id":"2507523074","title":"Tevogen Bio Enters Agreement to Receive up to $10 Million of Non-Dilutive Grant Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2507523074","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507523074?lang=en_us&edition=fundamental","pubTime":"2025-01-29 04:49","pubTimestamp":1738097388,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250128:nTUABVJ0P0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MSFT","LU0868494617.USD","LU0792757196.USD","LU1316542783.SGD","LU1429558221.USD","LU1917777945.USD","BK4576","LU0289941410.SGD","LU0894485498.HKD","IE00B5949003.HKD","LU2041044095.USD","LU1720051108.HKD","LU0354030511.USD","LU0203202063.USD","LU2506952097.USD","LU1334329650.SGD","LU2286300806.USD","IE00BMPRXQ63.HKD","LU1043141123.HKD","LU0965509010.AUD","TVGN","LU1815336760.USD","LU2242650005.HKD","IE0004445015.USD","LU2065169927.USD","LU1670627923.USD","LU1496350171.SGD","LU0950375773.USD","LU0784383803.USD","LU1181866309.USD","LU2458330169.SGD","LU2279689827.SGD","IE00BFXG0V08.USD","LU2023251221.USD","BK4525","LU2413666426.HKD","BK4532","LU0162691827.USD","LU0238689110.USD","LU1059921491.USD","SG9999014575.USD","LU1037948897.HKD","TVGNW","LU0072461881.USD","LU0345768153.USD","LU0426412945.USD","LU1366333091.USD","LU0128525929.USD","LU0109391861.USD","LU2028103732.USD"],"gpt_icon":0},{"id":"2507525308","title":"Press Release: Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2507525308","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507525308?lang=en_us&edition=fundamental","pubTime":"2025-01-29 04:49","pubTimestamp":1738097340,"startTime":"0","endTime":"0","summary":"-- The grant funding will further Tevogen Bio's mission to develop therapies. -- Tevogen Bio may also utilize the grant funding to further expand its. -- This grant is in addition to the previously announced $36 million loan. The receipt of the grant was not dilutive to existing Tevogen Bio shareholders and comes at a time when the Company is acutely focused on furthering its mission through expansion of its artificial intelligence efforts, Tevogen.AI. Tevogen Bio remains committed to efficient operations and anticipates utilizing the grant in a judicious manner.Tevogen Bio is a clinical-stage specialty immunotherapy company harnessing one of nature's most powerful immunological weapons, CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the significant unmet needs of large patient populations. Tevogen Bio Leadership believes that susta","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0082616367.USD","LU1244550494.USD","LU0312595415.SGD","LU0964807845.USD","LU2417539215.USD","LU1791710582.SGD","IE0004445015.USD","MSFT","LU1712237335.SGD","LU1181866309.USD","LU1235294995.USD","LU0316494557.USD","LU1435385759.SGD","LU0823417737.USD","LU0757359368.USD","LU1571399168.USD","LU1032466523.USD","BK4525","LU0889565833.HKD","LU2092937221.SGD","TVGN","LU2244417387.USD","LU1236620750.USD","IE00BWXC8680.SGD","LU0158827948.USD","LU1642822529.SGD","LU0310800379.SGD","LU2271345857.HKD","IE00BBT3K403.USD","LU0203201768.USD","LU0784385170.HKD","LU1564329115.USD","LU1718418525.SGD","LU2095319765.USD","LU2357305700.SGD","IE00BZ1G4Q59.USD","LU1323610961.USD","LU0708994859.HKD","LU1064131342.USD","LU0894486033.HKD","IE00BKDWB100.SGD","IE00BK4W5M84.HKD","LU2362541273.HKD","BK4527","LU2065171311.SGD","LU1003077747.HKD","LU1496350502.SGD","LU0348723411.USD","BK4592","LU2463028550.USD"],"gpt_icon":1},{"id":"2506567589","title":"Tevogen Bio CEO Congratulates Lynne Patton on Being Appointed Deputy Assistant to the President and Director of Minority Outreach","url":"https://stock-news.laohu8.com/highlight/detail?id=2506567589","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506567589?lang=en_us&edition=fundamental","pubTime":"2025-01-28 03:24","pubTimestamp":1738005873,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nTUA1LZMCS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2506258320","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2506258320","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506258320?lang=en_us&edition=fundamental","pubTime":"2025-01-28 02:20","pubTimestamp":1738002017,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings  said late Friday that it broadened its relationship with Microsoft  to expand its artificial intelligence-focused collaboration while building a technology designed to help with predictive precision T-cell targeting.Shares of Tevogen advanced 30% as intraday trading volume soared to more than 48.5 million from a daily average of about 2.9 million.Aurora Mobile  said Monday that its business-oriented AI agent platform GPTBots.ai integrated the DeepSeek R1 large language model.Shares skyrocketed 166% as intraday trading volume surged to over 28.5 million from a daily average of about 15,000.Akero Therapeutics  said Monday a phase 2b study of its lead product candidate, efruxifermin, showed a \"statistically significant\" reversal of compensated cirrhosis caused by metabolic dysfunction-associated steatohepatitis, or MASH.Shares surged more than 91% as intraday trading volume catapulted to over 11.7 million from a daily average of about 723,000.Price: 1.75, Change: +0.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4577","LU0757359368.USD","LU0476273544.USD","LU1791710400.SGD","LU1983260115.SGD","LU2023250504.SGD","BK4598","LU2092937148.SGD","LU0345770993.USD","LU0823417737.USD","LU1934455194.USD","LU2505996681.GBP","IE0034235295.USD","BK4139","SG9999014880.SGD","LU2213496289.HKD","LU1066053197.SGD","LU0109391861.USD","LU0882574139.USD","LU1934455277.USD","LU0124676726.USD","LU1633808545.USD","LU1035773651.USD","TVGN","IE00BMPRXN33.USD","MSFT","LU1720051017.SGD","AKRO","JG","LU0738911758.USD","LU0345774631.USD","LU1804176565.USD","LU1791710582.SGD","IE00BKVL7J92.USD","LU0127658192.USD","IE00B3S45H60.SGD","BK4534","LU0545562505.USD","LU2236285917.USD","LU0345768153.USD","LU2362540622.SGD","IE00B1XK9C88.USD","LU1145028129.USD","LU2764262908.HKD","LU1697837992.HKD","SGXZ99366536.SGD","SG9999001077.SGD","LU0444971666.USD","LU0203201768.USD","LU0095938881.EUR"],"gpt_icon":1},{"id":"2506309070","title":"BUZZ-U.S. STOCKS ON THE MOVE-Sagimet Biosciences, Sage Therapeutics, Qorvo","url":"https://stock-news.laohu8.com/highlight/detail?id=2506309070","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506309070?lang=en_us&edition=fundamental","pubTime":"2025-01-27 23:49","pubTimestamp":1737992980,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Sagimet Biosciences, Sage Therapeutics, QorvoEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nL3N3ON13C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEE","AZPN","2NVD.UK","CNP","EVRG","NVD","NVIW.SI","3NVD.UK","ASAN","NVDU","TLN","NEE","COF","NVD3.UK","ALLK","NVD2.UK","RL","SGMT","QXO","SBAC","IRM","X","NVDA","AKRO","BECN","EQT","NVDS","VST","T","NVDY","EQIX","QRVO","NVDD","TVGN","HUT","CEG","DLR","LNG","ET"],"gpt_icon":1},{"id":"2506830836","title":"Tevogen Bio Shares up 28% After Co to Expand Microsoft AI Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2506830836","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506830836?lang=en_us&edition=fundamental","pubTime":"2025-01-27 22:32","pubTimestamp":1737988346,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nFWN3ON0Q1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"2506781376","title":"BUZZ-U.S. STOCKS ON THE MOVE-AT&T, Tevogen Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2506781376","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506781376?lang=en_us&edition=fundamental","pubTime":"2025-01-27 20:18","pubTimestamp":1737980318,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-AT&T, Tevogen Bio Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nL3N3ON0QE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNVD.UK","LU1551013342.USD","NVDS","NVD","T","HUT","NVDU","LU1084165304.USD","QCOM","2NVD.UK","IE0004445015.USD","3NVD.UK","LU2213496289.HKD","AVGO","SG9999003800.SGD","LU1267930730.SGD","HK0000320264.USD","NVD3.UK","LU0348723411.USD","MGLD","LU2210150020.SGD","NVDD","NVIW.SI","LU1989763005.USD","LU0661504455.SGD","LU0472753341.HKD","NVDY","LU0690374615.EUR","NVD2.UK","NVDA","NVDS.UK","NVDX","LU2048586759.USD","X","NEE","LU2286300806.USD","LU1923622614.USD","TVGN","LU0545562505.USD","IE00B29SXK94.USD","LU2092937221.SGD"],"gpt_icon":1},{"id":"2506375991","title":"BUZZ-Tevogen Bio jumps on expanded Microsoft AI collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2506375991","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506375991?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:53","pubTimestamp":1737978834,"startTime":"0","endTime":"0","summary":"BUZZ-Tevogen Bio jumps on expanded Microsoft AI collaboration** Shares of drug developer Tevogen Bio TVGN.O rise ~48% to $2 premarket** On Friday, TVGN said it is expanding its partnership with Microsoft MSFT.O to use AI to improve its immunotherapy treatments** Co's proprietary tech, PredicTcell, will be developed on Microsoft's Azure cloud platform to identify precise T-cell targets - TVGN** TVGN said it is also using MSFT's AI tools and Azure cloud platform to proactively investigate potential treatments for human papillomavirus - viral infection that can cause genital warts and certain types of cancer** Last year, TVGN announced its partnership with Microsoft, and its shares surged to ~54%** TVGN fell 90.7% in 2024  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nL3N3ON0LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFSS7M15.SGD","LU0784383803.USD","LU1989773731.SGD","LU0345768740.USD","LU0444971666.USD","TVGN","IE0034235188.USD","LU0708994859.HKD","LU1868837300.USD","LU0079474960.USD","LU0545039389.USD","LU0320765059.SGD","LU1548497426.USD","LU0061475181.USD","LU2360032135.SGD","LU0251132253.USD","SG9999014898.SGD","GB00B4LPDJ14.GBP","GB00BDT5M118.USD","SG9999018857.SGD","LU2237957902.USD","LU0994945656.USD","LU0689472784.USD","LU2133065610.SGD","LU1153585028.USD","MSFT","LU0345770308.USD","LU1823568750.SGD","LU0234570918.USD","LU1623119135.USD","LU0314104364.USD","LU1814569148.SGD","LU0823421416.USD","LU0949170772.SGD","LU1280957306.USD","LU0106261372.USD","LU1003077747.HKD","LU2191332357.HKD","LU0006306889.USD","LU2065170008.USD","IE00BJTD4V19.USD","LU0289941410.SGD","LU0943347566.SGD","LU0238689110.USD","BK4532","BK4588","LU0879622024.SGD","LU2237443895.HKD","LU2236285917.USD","LU2279689827.SGD"],"gpt_icon":1},{"id":"2506737763","title":"Tevogen Bio Stock Soars on Expanded Team-Up with Microsoft","url":"https://stock-news.laohu8.com/highlight/detail?id=2506737763","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506737763?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:37","pubTimestamp":1737977820,"startTime":"0","endTime":"0","summary":"Shares of Tevogen Bio surged after the company said it has broadened its relationship with Microsoft in an AI-focused collaboration to develop the biotech's proprietary technology.The stock was up 52% at $2.06 in premarket trading on Monday. Shares were trading at $7.58 this time a year ago.The Warren, N.J., company said after the market closed last week that Microsoft is using its AI and cloud capabilities to help build Tevogen's PredicTcell technology, which is designed for predictive precision T-cell targeting.Microsoft's health and life sciences domain expertise should accelerate Tevogen's target identification and pre-clinical processes, the company said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000ITXATA3.USD","LU1732800096.USD","LU1670627923.USD","BK4581","IE00BQXX3D17.EUR","TISI","SG9999014914.USD","SGXZ81514606.USD","LU0256863902.USD","LU1868836591.USD","LU1181866309.USD","LU0354030438.USD","LU1366192091.USD","LU0949170426.SGD","LU0225283273.USD","LU1815336760.USD","LU0316494557.USD","LU0960925559.SGD","LU1429558221.USD","LU1917777945.USD","LU1934455277.USD","MSFT","SG9999001424.SGD","IE00BLSP4239.USD","LU0784383803.USD","BK4566","LU0494093205.USD","LU2237443978.SGD","LU1914381329.SGD","LU2089283258.USD","BK4538","LU1043141123.HKD","LU0757359368.USD","LU2237957902.USD","LU0345768153.USD","SG9999018865.SGD","IE00BJTD4V19.USD","LU0390134368.USD","BK4548","LU1852331112.SGD","LU1670628061.USD","LU1196500208.SGD","LU2286300806.USD","IE00BDRTCR15.USD","TVGN","LU1064131342.USD","SG9999018857.SGD","LU0642271901.SGD","LU1496350171.SGD","LU0082616367.USD"],"gpt_icon":1},{"id":"2506243743","title":"Tevogen Bio Shares Rise 60% at $2.16 Premarket After Co to Broaden AI Collaboration With Microsoft","url":"https://stock-news.laohu8.com/highlight/detail?id=2506243743","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506243743?lang=en_us&edition=fundamental","pubTime":"2025-01-27 17:50","pubTimestamp":1737971429,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nL3N3ON0II:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"1132878034","title":"Tevogen Stock Surges on Expanded Microsoft AI Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=1132878034","media":"Seeking Alpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132878034?lang=en_us&edition=fundamental","pubTime":"2025-01-25 11:15","pubTimestamp":1737774900,"startTime":"0","endTime":"0","summary":"Tevogen Bio  stock jumped nearly 26% post-market after the company announced it has expanded its relationship with Microsoft  to broaden their AI-focused collaboration and build its PredicTcell technology for predictive precision T cell targeting.The Tevogen.AI initiative will integrate Microsoft's AI tools and Azure cloud platform to expand Tevogen's  ExacTcell preclinical pipeline. The initiative will also aim to develop proprietary algorithms to decode HLA-T cell interactions, according to a ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4398655-tevogen-stock-rallies-on-expanded-microsoft-ai-collaboration","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tevogen Stock Surges on Expanded Microsoft AI Collaboration","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1728464409321","symbols":["MSFT","TVGN"],"gpt_icon":1},{"id":"2506812361","title":"Stocks to Watch: Richardson Electronics, Tevogen Bio Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2506812361","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506812361?lang=en_us&edition=fundamental","pubTime":"2025-01-25 07:45","pubTimestamp":1737762300,"startTime":"0","endTime":"0","summary":"Richardson Electronics sold a majority of its healthcare arm to medical-imaging company DirectMed. The maker of engineered solutions and green-energy products said the deal will simplify its business, improve its financial model and allow it to prioritize opportunities within higher-growth markets. It also entered an exclusive 10-year global supply agreement with DirectMed under which it will supply the company with repaired Siemens CT X-ray tubes. Shares rise 12%, to $14.70, in after-hours trading.Tevogen Bio Holdings expanded its artificial-intelligence partnership with Microsoft. The immunotherapy biotech company said its AI effort, Tevogen.AI, will integrate Microsoft's advanced AI tools and the Microsoft Azure cloud platform to perform simulations that will accelerate the identification of new targets. It will additionally create new algorithms to decode the interactions between human leukocyte antigens and T cells, enhancing the company's understanding of immune responses. Shares","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFSS7M15.SGD","LU2756315318.SGD","LU0642271901.SGD","LU0048584097.USD","LU0719512351.SGD","LU0345768153.USD","TVGN","LU1988902786.USD","LU1868837300.USD","LU1674673428.USD","LU2125154935.USD","LU1084165304.USD","LU2237443549.SGD","LU0265550359.USD","LU0289961442.SGD","BK4504","LU0094547139.USD","LU2361044865.SGD","IE00BLSP4452.SGD","LU1244550494.USD","LU2133065610.SGD","IE00BYQQ9H92.USD","LU0965509010.AUD","MSFT","RELL","LU0345770308.USD","LU1043141123.HKD","LU1823568750.SGD","LU0069063385.USD","LU1267930573.SGD","LU2087621335.USD","LU0690374961.EUR","SG9999001424.SGD","LU0823434583.USD","LU1435385759.SGD","LU0345770993.USD","LU2420271590.USD","LU0158827781.USD","LU0171293334.USD","LU1670711040.USD","LU1629891620.HKD","BK4554","LU0787776722.HKD","LU0823417737.USD","SG9999014559.SGD","IE00B3SWFQ91.USD","IE00BJTD4V19.USD","LU0095938881.EUR","LU1366192091.USD","LU1934455863.HKD"],"gpt_icon":1},{"id":"2506113598","title":"BRIEF-Tevogen Bio Broadens Relationship With Microsoft To Deepen Artificial Intelligence Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2506113598","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506113598?lang=en_us&edition=fundamental","pubTime":"2025-01-25 06:46","pubTimestamp":1737758774,"startTime":"0","endTime":"0","summary":"BRIEF-Tevogen Bio Broadens Relationship With Microsoft To Deepen Artificial Intelligence CollaborationJan 24 (Reuters) - Microsoft Corp MSFT.O:TEVOGEN BIO BROADENS RELATIONSHIP WITH MICROSOFT TO DEEPE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250124:nTUA8TJBL1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002224.SGD","LU0784384876.USD","LU2023250330.USD","BK4525","LU1244550577.SGD","LU1691799644.USD","LU0080751232.USD","LU2506952097.USD","LU0157215616.USD","IE00B4YYXB79.USD","LU0868494617.USD","LU1267930573.SGD","LU2764262908.HKD","SGXZ81514606.USD","MSFT","LU0187121727.USD","LU0823434583.USD","LU0426412945.USD","BK4548","IE0004445015.USD","LU0690374961.EUR","LU0792757196.USD","LU2237443382.USD","LU2362540622.SGD","LU0095938881.EUR","LU0347712357.USD","LU2592432038.USD","LU0689626769.HKD","LU2210149790.SGD","LU2111349929.HKD","LU2361045086.USD","LU2552382215.SGD","LU1934455863.HKD","IE00BJTD4N35.SGD","LU1697837992.HKD","LU1642822529.SGD","LU1778281490.HKD","LU1868837136.USD","TVGN","LU0310800379.SGD","LU0353189763.USD","TVGNW","LU2065171311.SGD","LU1868836591.USD","LU1935042215.USD","LU1988902786.USD","LU2237957811.SGD","LU0289739343.SGD","LU0889565833.HKD","LU0057025933.USD"],"gpt_icon":1},{"id":"2506811444","title":"Tevogen Bio announces AI collaboration with Microsoft","url":"https://stock-news.laohu8.com/highlight/detail?id=2506811444","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506811444?lang=en_us&edition=fundamental","pubTime":"2025-01-25 06:40","pubTimestamp":1737758413,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc. (TVGN) announced that it has broadened its relationship with Microsoft (MSFT) to broaden its AI-focused collaboration and...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-bio-announces-ai-collaboration-with-microsoft?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-bio-announces-ai-collaboration-with-microsoft?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0784384876.USD","LU1244550577.SGD","GB00BDT5M118.USD","LU1934455194.USD","LU1037948541.HKD","LU0965508806.USD","LU2506951875.HKD","SG9999014575.USD","LU0784383803.USD","BK4534","LU0323239441.USD","LU1334329650.SGD","LU2592432038.USD","MSFT","LU2362541513.USD","LU2236285917.USD","IE00BMPRXR70.SGD","LU0171293334.USD","LU0784385840.USD","LU1046421795.USD","LU1988902786.USD","LU2361044865.SGD","LU1366192091.USD","LU0310800379.SGD","LU2237957902.USD","LU1066051811.HKD","SG9999014880.SGD","LU2237957811.SGD","LU0823417653.USD","LU1236620750.USD","LU2213496289.HKD","LU2106854487.HKD","LU1066051498.USD","SG9999014542.SGD","LU0029864427.USD","LU1823568750.SGD","IE0004091025.USD","BK4504","IE00B4JS1V06.HKD","LU0265550359.USD","TVGN","LU2250418816.HKD","IE00BZ1G4Q59.USD","IE0034235303.USD","LU2237443382.USD","LU1548497426.USD","LU0642271901.SGD","LU2023250330.USD","BK4503","LU0960925559.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://semperparatusspac.com","stockEarnings":[{"period":"1week","weight":0.0748},{"period":"1month","weight":0.264},{"period":"3month","weight":0.0822},{"period":"6month","weight":1.2571},{"period":"1year","weight":-0.842},{"period":"ytd","weight":0.534}],"compareEarnings":[{"period":"1week","weight":0.0149},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0409},{"period":"6month","weight":0.0999},{"period":"1year","weight":0.2145},{"period":"ytd","weight":0.0403}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tevogen Bio Holdings Inc. operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients. It is also developing TVGN 601 for treating multiple sclerosis; TVGN 930 for the treatment of Epstein-Barr virus associated lymphomas; TVGN 920 for treating cervical cancer; and TVGN 960 for the treatment of mouth and throat cancer. The company was founded in 2020 and is headquartered in Warren, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.026634},{"month":2,"riseRate":1,"avgChangeRate":0.144113},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.169363},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.236796},{"month":5,"riseRate":0,"avgChangeRate":-0.07274},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.036302},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.035247},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.058816},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.094697},{"month":10,"riseRate":1,"avgChangeRate":1.958555},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.153562},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.065928}],"exchange":"NASDAQ","name":"Tevogen Bio Holdings","nameEN":"Tevogen Bio Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tevogen Bio Holdings(TVGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tevogen Bio Holdings(TVGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tevogen Bio Holdings,TVGN,Tevogen Bio Holdings股票,Tevogen Bio Holdings股票老虎,Tevogen Bio Holdings股票老虎国际,Tevogen Bio Holdings行情,Tevogen Bio Holdings股票行情,Tevogen Bio Holdings股价,Tevogen Bio Holdings股市,Tevogen Bio Holdings股票价格,Tevogen Bio Holdings股票交易,Tevogen Bio Holdings股票购买,Tevogen Bio Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tevogen Bio Holdings(TVGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tevogen Bio Holdings(TVGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction